Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Escaned, JavierRyan, Nicola
Mejía-Rentería, Hernán
Cook, Christopher M
Dehbi, Hakim-Moulay
Alegria-Barrero, Eduardo
Alghamdi, Ali
Al-Lamee, Rasha
Altman, John
Ambrosia, Alphonse
Baptista, Sérgio B
Bertilsson, Maria
Bhindi, Ravinay
Birgander, Mats
Bojara, Waldemar
Brugaletta, Salvatore
Buller, Christopher
Calais, Fredrik
Silva, Pedro Canas
Carlsson, Jörg
Christiansen, Evald H
Danielewicz, Mikael
Di Mario, Carlo
Doh, Joon-Hyung
Erglis, Andrejs
Erlinge, David
Gerber, Robert T
Going, Olaf
Gudmundsdottir, Ingibjörg
Härle, Tobias
Hauer, Dario
Hellig, Farrel
Indolfi, Ciro
Jakobsen, Lars
Janssens, Luc
Jensen, Jens
Jeremias, Allen
Kåregren, Amra
Karlsson, Ann-Charlotte
Kharbanda, Rajesh K
Khashaba, Ahmed
Kikuta, Yuetsu
Krackhardt, Florian
Koo, Bon-Kwon
Koul, Sasha
Laine, Mika
Lehman, Sam J
Lindroos, Pontus
Malik, Iqbal S
Maeng, Michael
Matsuo, Hitoshi
Meuwissen, Martijn
Nam, Chang-Wook
Niccoli, Giampaolo
Nijjer, Sukhjinder S
Olsson, Hans
Olsson, Sven-Erik
Omerovic, Elmir
Panayi, Georgios
Petraco, Ricardo
Piek, Jan J
Ribichini, Flavo
Samady, Habib
Samuels, Bruce
Sandhall, Lennart
Sapontis, James
Sen, Sayan
Seto, Arnold H
Sezer, Murat
Sharp, Andrew S P
Shin, Eun-Seok
Singh, Jasvindar
Takashima, Hiroaki
Talwar, Suneel
Tanaka, Nobuhiro
Tang, Kare
Van Belle, Eric
van Royen, Niels
Varenhorst, Christoph
Vinhas, Hugo
Vrints, Christiaan J
Walters, Darren
Yokoi, Hiroyoshi
Fröbert, Ole
Patel, Manesh R
Serruys, Patrick
Davies, Justin E
Götberg, Matthias
Issue Date
2018-08-13
Metadata
Show full item recordCitation
JACC. Cardiovascular interventions 2018;11(15):1437-1449Abstract
The aim of this study was to investigate the clinical outcomes of patients deferred from coronary revascularization on the basis of instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) measurements in stable angina pectoris (SAP) and acute coronary syndromes (ACS). Assessment of coronary stenosis severity with pressure guidewires is recommended to determine the need for myocardial revascularization. The safety of deferral of coronary revascularization in the pooled per-protocol population (n = 4,486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) randomized clinical trials was investigated. Patients were stratified according to revascularization decision making on the basis of iFR or FFR and to clinical presentation (SAP or ACS). The primary endpoint was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization at 1 year. Coronary revascularization was deferred in 2,130 patients. Deferral was performed in 1,117 patients (50%) in the iFR group and 1,013 patients (45%) in the FFR group (p < 0.01). At 1 year, the MACE rate in the deferred population was similar between the iFR and FFR groups (4.12% vs. 4.05%; fully adjusted hazard ratio: 1.13; 95% confidence interval: 0.72 to 1.79; p = 0.60). A clinical presentation with ACS was associated with a higher MACE rate compared with SAP in deferred patients (5.91% vs. 3.64% in ACS and SAP, respectively; fully adjusted hazard ratio: 0.61 in favor of SAP; 95% confidence interval: 0.38 to 0.99; p = 0.04).Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://www.sciencedirect.com/science/article/pii/S1936879818311439ae974a485f413a2113503eed53cd6c53
10.1016/j.jcin.2018.05.029
Scopus Count
Collections
Related articles
- Revascularization Deferral of Nonculprit Stenoses on the Basis of Fractional Flow Reserve: 1-Year Outcomes of 8,579 Patients.
- Authors: Cerrato E, Mejía-Rentería H, Dehbi HM, Ahn JM, Cook C, Dupouy P, Baptista SB, Raposo L, Van Belle E, Götberg M, Davies JE, Park SJ, Escaned J
- Issue date: 2020 Aug 24
- Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.
- Authors: Kim CH, Koo BK, Dehbi HM, Lee JM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys PW, Escaned J, Davies JE
- Issue date: 2019 Oct 28
- Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial.
- Authors: Andell P, Berntorp K, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Venetsanos D, Erlinge D, Fröbert O, Koul S, Reitan C, Götberg M
- Issue date: 2018 Oct 22
- Clinical Outcomes According to Fractional Flow Reserve or Instantaneous Wave-Free Ratio in Deferred Lesions.
- Authors: Lee JM, Shin ES, Nam CW, Doh JH, Hwang D, Park J, Kim KJ, Zhang J, Ahn C, Koo BK
- Issue date: 2017 Dec 26
- Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
- Authors: DEFINE-FLAIR Trial Investigators., Lee JM, Choi KH, Koo BK, Dehbi HM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys P, Escaned J, Davies JE
- Issue date: 2019 Sep 1